Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration

Journal of the Neurological Sciences

Volumn 180, Issue 1-2, 2000, Pages 62-65

  Vogels, O J M ^a,b   Veltman, J ^a   Oyen, W J G ^a   Horstink, M W I M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Dopamine D2 receptors; Down regulation of D2 receptors; Multiple system atrophy

Indexed keywords

DOPAMINE 2 RECEPTOR; GLUTAMINE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRADYKINESIA; CELL DEGENERATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; NEURORADIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; SHY DRAGER SYNDROME;

AMYOTROPHIC LATERAL SCLEROSIS; BENZAMIDES; BINDING SITES; DOPAMINE ANTAGONISTS; DOWN-REGULATION; FEMALE; HUMANS; HYPOKINESIA; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; MUSCLE WEAKNESS; NEOSTRIATUM; NERVE DEGENERATION; PYRROLIDINES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2;

EID: 0034326236     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00429-9     Document Type: Article

References (15)

1. Multiple system atrophy
2. Decreased striatal dopamine-receptor binding in sporadic ALS: Glutamate hyperactivity?
3. Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state
4. 76Br]bromolisuride binding in the excitotoxically lesioned caudate-putamen of nonhuman primates studied using positron emission tomography
5. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors
6. Consensus statement on the diagnosis of multiple system atrophy
7. Neuroreceptor imaging: New developments in PET and SPECT imaging of neuroreceptor binding (including dopamine transporters, vesicle transporters and post synaptic receptor sites)
8. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123]IPT single photon emission computed tomography
9. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing
10. Slowness of movement in Parkinson's Disease
11. Excitotoxicity in ALS
12. A controlled trial of riluzole in amyotrophic lateral sclerosis
13. High affinity uptake of glutamate in terminals of corticostriatal axons
14. Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum
15. Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene